Abel ED., Peroni O., Kim JK., Kim YB., Boss O., Hadro E., Minnemann T., Shulman GI., Kahn BB. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature. 409:729–733. 2001.
Article
Ashcroft FM. ATP-sensitive potassium channelopathies: focus on insulin secretion. J Clin Invest. 115:2047–2058. 2005.
Article
Bajaj M., Defronzo RA. Metabolic and molecular basis of insulin resistance. J Nucl Cardiol. 10:311–323. 2003.
Article
Boyd JJ., Contreras I., Kern M., Tapscott EB., Downes DL., Frisell WR., Dohm GL. Effect of a high-fat-sucrose diet on in vivo insulin receptor kinase activation. Am J Physiol. 259:E111–116. 1990.
Eisenberg ML., Maker AV., Slezak LA., Nathan JD., Sritharan KC., Jena BP., Geibel JP., Andersen DK. Insulin receptor (IR) and glucose transporter 2 (GLUT2) proteins form a complex on the rat hepatocyte membrane. Cell Physiol Biochem. 15:51–58. 2005.
Article
Handberg A., Vaag A., Damsbo P., Beck-Nielsen H., Vinten J. Expression of insulin regulatable glucose transporters in skeletal muscle from type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 33:625–627. 1990.
Article
Hughes VA., Fiatarone MA., Fielding RA., Kahn BB., Ferrara CM., Shepherd P., Fisher EC., Wolfe RR., Elahi D., Evans WJ. Exercise increases muscle GLUT-4 levels and insulin action in subjects with impaired glucose tolerance. Am J Physiol. 264:E855–862. 1993.
Article
Kahn BB. Lilly lecture 1995. Glucose transport: pivotal step in insulin action. Diabetes. 45:1644–1654. 1996.
Article
Kawamori R., Morishima T., Kubota M., Matsuhisa M., Ikeda M., Kamada T. Influence of oral sulfonylurea agents on hepatic glucose uptake. Diabetes Res Clin Pract. 28(Suppl):S109–113. 1995.
Article
Kawano K., Hirashima T., Mori S., Saitoh Y., Kurosumi M., Natori T. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes. 41:1422–1428. 1992.
Article
Kern PA., Saghizadeh M., Ong JM., Bosch RJ., Deem R., Simsolo RB. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest. 95:2111–2119. 1995.
Article
Koike T., Tomoda F., Kinuno H., Inoue H., Takata M. Abnormal renal structural alterations during the development of diabetes mellitus in Otsuka Long-Evans Tokushima Fatty rats. Acta Physiol Scand. 184:73–81. 2005.
Article
Kumar N., Dey CS. Gliclazide increases insulin receptor tyrosine phosphorylation but not p38 phosphorylation in insulin-resistant skeletal muscle cells. J Exp Biol. 205:3739–3746. 2002.
Article
Lebovitz HE., Feinglos MN., Bucholtz HK., Lebovitz FL. Potentiation of insulin action: a probable mechanism for the anti-diabetic action of sulfonylurea drugs. J Clin Endocrinol Metab. 45:601–604. 1977.
Article
Marin P., Rebuffe-Scrive M., Smith U., Bjorntorp P. Glucose uptake in human adipose tissue. Metabolism. 36:1154–1160. 1987.
Article
Miki T., Nagashima K., Tashiro F., Kotake K., Yoshitomi H., Tamamoto A., Gonoi T., Iwanaga T., Miyazaki J., Seino S. Defective insulin secretion and enhanced insulin action in KATP channel-deficient mice. Proc Natl Acad Sci U S A. 95:10402–10406. 1998.
Minami K., Morita M., Saraya A., Yano H., Terauchi Y., Miki T., Kuriyama T., Kadowaki T., Seino S. ATP-sensitive K+ channel-mediated glucose uptake is independent of IRS-1/phosphatidylinositol 3-kinase signaling. Am J Physiol Endocrinol Metab. 285:E1289–1296. 2003.
Mori Y., Komiya H., Kurokawa N., Tajima N. Comparison of the effects of glimepiride and glibenclamide on adipose tissue tumour necrosis factor-alpha mRNA expression and cellularity. Diabetes Obes Metab. 6:28–34. 2004.
Article
Muller G., Satoh Y., Geisen K. Extrapancreatic effects of sulfonylureas-a comparison between glimepiride and conventional sulfonylureas. Diabetes Res Clin Pract. 28(Suppl):S115–137. 1995.
Pedersen O., Bak JF., Andersen PH., Lund S., Moller DE., Flier JS., Kahn BB. Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes. 39:865–870. 1990.
Article
Rodriguez E., Pulido N., Romero R., Arrieta F., Panadero A., Rovira A. Phosphatidylinositol 3-kinase activation is required for sulfonylurea stimulation of glucose transport in rat skeletal muscle. Endocrinology. 145:679–685. 2004.
Proks P., Reimann F., Green N., Gribble F., Ashcroft F. Sulfonylurea stimulation of insulin secretion. Diabetes. 51(Suppl 3):S368–376. 2002.
Article
Schernthaner G., Grimaldi A., Di Mario U., Drzewoski J., Kempler P., Kvapil M., Novials A., Rottiers R., Rutten GE., Shaw KM. GUIDE study: double-blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patients. Eur J Clin Invest. 34:535–542. 2004.
Article
Toide K., Man ZW., Asahi Y., Sato T., Nakayama N., Noma Y., Oka Y., Shima K. Glucose transporter levels in a male spontaneous non-insulin-dependent diabetes mellitus rat of the Otsuka Long-Evans Tokushima Fatty strain. Diabetes Res Clin Pract. 38:151–160. 1997.
Article
UKPDS. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 352:837–853. 1998.
Wang R., Liu X., Hentges ST., Dunn-Meynell AA., Levin BE., Wang W., Routh VH. The regulation of glucose-excited neurons in the hypothalamic arcuate nucleus by glucose and feeding-relevant peptides. Diabetes. 53:1959–1965. 2004.
Article
Wasada T., Yano T., Ohta M., Yui N., Iwamoto Y. ATP-Sensitive potassium channels modulate glucose transport in cultured human skeletal muscle cells. Endocr J. 48:369–375. 2001.
Article